Glyburide; Metformin Hydrochloride Patent Expiration
Glyburide; Metformin Hydrochloride is Used for managing blood sugar levels in individuals with type 2 diabetes. It was first introduced by Bristol Myers Squibb
Glyburide; Metformin Hydrochloride Patents
Given below is the list of patents protecting Glyburide; Metformin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Glucovance |
US6303146 (Pediatric) | Solid oral dosage form comprising a combination of metformin and glibenclamide |
Jan 14, 2020
(Expired) | Bristol Myers Squibb |
| Glucovance | US6303146 | Solid oral dosage form comprising a combination of metformin and glibenclamide |
Jul 14, 2019
(Expired) | Bristol Myers Squibb |
Glyburide; Metformin Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List